Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Show other versions (1)

<h4>Background</h4> <p>The replication-competent recombinant vesicular stomatitis virus (rVSV)–based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa.</p> <h4>Methods</h...

Full description

Bibliographic Details
Main Authors: Agnandji, S, Huttner, A, Zinser, M, Njuguna, P, Dahlke, C, Fernandes, J, Yerly, S, Dayer, J, Kraehling, V, Kasonta, R, Adegnika, A, Altfeld, M, Auderset, F, Bache, E, Biedenkopf, N, Borregaard, S, Brosnahan, J, Burrow, R, Combescure, C, Desmeules, J, Eickmann, M, Fehling, S, Finckh, A, Goncalves, A, Grobusch, M, Hooper, J, Jambrecina, A, Kabwende, A, Kaya, G, Kimani, D, Lell, B, Lemaître, B, Lohse, A, Massinga-Loembe, M, Matthey, A, Mordmüller, B, Nolting, A, Ogwang, C, Ramharter, M, Schmidt-Chanasit, J, Schmiedel, S, Silvera, P, Stahl, F, Staines, H, Strecker, T, Stubbe, H, Tsofa, B, Zaki, S, Fast, P, Moorthy, V, Kaiser, L, Krishna, S, Becker, S, Kieny, M, Bejon, P, Kremsner, P, Addo, M, Siegrist, C
Format: Journal article
Published: Massachusetts 2016

Similar Items